{"gene":"ASF1A","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2005,"finding":"ASF1a forms a physical complex with HIRA that is rate-limiting for formation of macroH2A-containing senescence-associated heterochromatin foci (SAHF) and onset of senescence-associated cell cycle exit. As cells approach senescence, HIRA enters PML nuclear bodies where it transiently colocalizes with HP1 proteins prior to HP1 incorporation into SAHF; ASF1a is required for efficient SAHF formation and senescence-associated cell cycle exit.","method":"Co-immunoprecipitation, dominant-negative mutants, siRNA knockdown, immunofluorescence/colocalization in primary human cells approaching senescence","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP establishing complex, multiple loss-of-function approaches (dominant-negative and knockdown) with defined cellular phenotypes, replicated in subsequent studies","pmids":["15621527"],"is_preprint":false},{"year":2006,"finding":"Crystal structure of ASF1a-HIRA heterodimer shows the HIRA B domain forms an antiparallel beta-hairpin binding perpendicular to the beta-sandwich of ASF1a via beta-sheet, salt bridge, and van der Waals contacts. The N- and C-terminal regions of ASF1a and ASF1b determine differential affinity for HIRA. CAF-1 p60 uses B domain-like motifs to competitively bind ASF1a, mutually exclusive with HIRA binding.","method":"X-ray crystallography, biochemical binding assays, mutational analysis","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and biochemical competition assays in a single rigorous study","pmids":["16980972"],"is_preprint":false},{"year":2007,"finding":"HIRA/ASF1a pathway cooperates with pRB and p53 in parallel to form SAHF; the HIRA/ASF1a and pRB pathways converge through the DNAJ-domain protein DNAJA2. HIRA's localization to PML bodies is required for SAHF formation, but this translocation occurs independently of functional pRB and p53.","method":"Dominant-negative HIRA mutants, PML-RARα disruption of PML bodies, epistasis analysis, co-immunoprecipitation in primary human cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple loss-of-function approaches and defined pathway placement, replicated across multiple senescence triggers","pmids":["17242198"],"is_preprint":false},{"year":2008,"finding":"UBN1 (human ortholog of yeast Hpc2p) is a component of the HIRA/ASF1a chromatin-remodeling complex. The Hpc2-related domain (HRD) of UBN1 directly interacts with the N-terminal WD repeats of HIRA. UBN1 is indispensable for SAHF formation and associates with histone H3K9 methyltransferase activity at proliferation-promoting genes repressed in senescence.","method":"Co-immunoprecipitation, direct binding assays with recombinant proteins, siRNA knockdown, chromatin immunoprecipitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, direct recombinant protein binding, knockdown with defined SAHF phenotype, multiple orthogonal methods","pmids":["19029251"],"is_preprint":false},{"year":2011,"finding":"ASF1a is required for post-UV-repair restoration of H3K56 acetylation (H3K56Ac), which in turn is needed for dephosphorylation of γ-H2AX and cellular recovery from checkpoint arrest. ATM checkpoint kinase regulates H3K56Ac restoration. Completion of DNA damage repair itself is not dependent on ASF1a or H3K56Ac.","method":"siRNA knockdown, chromatin immunoprecipitation, immunofluorescence for γ-H2AX in UV-irradiated human cells","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockdown with defined molecular phenotype (H3K56Ac, γ-H2AX), single lab with multiple orthogonal readouts","pmids":["21727091"],"is_preprint":false},{"year":2011,"finding":"CABIN1 is a functional fourth member of the human HIRA/UBN1/ASF1a (HUCA) quaternary complex. HIRA acts as a scaffold to assemble UBN1, ASF1a, and CABIN1. The HUCA complex preferentially deposits histone variant H3.3 into chromatin in a DNA replication-independent manner, and CABIN1 is involved in heterochromatinization of senescent cells.","method":"Co-immunoprecipitation at endogenous and ectopic expression levels, reconstitution of quaternary complex from recombinant proteins, mutational analysis, chromatin fractionation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — quaternary complex reconstituted from recombinant proteins, corroborated by endogenous Co-IP and mutational analysis, multiple orthogonal methods","pmids":["21807893"],"is_preprint":false},{"year":2011,"finding":"HIRA, but not ASF1a, is required for HP1-mediated formation of ALT-associated PML bodies (APBs) and large HP1 foci following p53/p21 pathway activation in ALT cells. HIRA and ASF1a co-localize inside PML bodies in normal fibroblasts approaching senescence, confirming a senescence-associated ASF1a/HIRA complex inside PML bodies.","method":"siRNA knockdown of HIRA vs. ASF1a, immunofluorescence, colocalization in ALT cells and normal fibroblasts","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — comparative knockdown of HIRA vs ASF1a dissecting pathway contributions, single lab with clear positive vs. negative functional outcomes","pmids":["21347226"],"is_preprint":false},{"year":2012,"finding":"ASF1a is required for chromatin assembly onto incoming herpes simplex virus 1 (HSV-1) DNA early during lytic infection. ASF1a knockdown reduced viral DNA protection from MNase digestion, increased transcription of immediate early genes ICP0 and ICP4 at 3 hpi, and decreased viral replication and growth.","method":"siRNA knockdown, MNase protection assay, RT-PCR, viral growth assay in HeLa cells","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple orthogonal readouts (MNase, transcription, viral replication), single lab","pmids":["22951827"],"is_preprint":false},{"year":2013,"finding":"ASF1a and ASF1b underwent subfunctionalization after vertebrate duplication. Regions outside the primary H3-H4 interaction surface (N- and C-terminal regions) determine preferential interactions of ASF1a versus ASF1b with distinct downstream H3-H4 chaperone complexes. ASF1a was relocated into an intron of MCM9 in tetrapod ancestors, providing a different genomic environment and replication timing context.","method":"Biochemical binding assays, evolutionary analysis, structural comparison","journal":"Molecular biology and evolution","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical binding assays demonstrating differential interactions, complemented by evolutionary analysis, single study","pmids":["23645555"],"is_preprint":false},{"year":2014,"finding":"Doxorubicin activates the ATR checkpoint pathway, which causes CRL1(βTRCP)-dependent ubiquitination and proteasomal degradation of ASF1a, leading to localized dechromatinization and repression of genes overlapping with clusters of stalled replication forks.","method":"Western blotting, ubiquitination assays, ATR inhibition and CRL1(βTRCP) dominant-negative studies, chromatin fractionation, gene expression analysis in cancer cells","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pathway components tested (ATR inhibition, proteasome inhibition, CRL1βTRCP dominants), single lab","pmids":["24700029"],"is_preprint":false},{"year":2014,"finding":"ASF1A is specifically enriched in the metaphase II human oocyte and is necessary for reprogramming of human adult dermal fibroblasts into iPSCs. Overexpression of ASF1A together with OCT4 in fibroblasts exposed to the oocyte-specific paracrine factor GDF9 is sufficient to reprogram them into pluripotent cells.","method":"Immunofluorescence localization, loss-of-function (knockdown), overexpression/reprogramming assay, iPSC characterization","journal":"Science (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and gain-of-function reprogramming experiments with pluripotency characterization, single lab","pmids":["25035411"],"is_preprint":false},{"year":2015,"finding":"The E2 ubiquitin-conjugating enzyme RAD6 is an evolutionarily conserved interacting protein of ASF1 that cooperates with the E3 ligase MDM2 to promote ubiquitin-proteasome-dependent turnover of ASF1A in human cells.","method":"Co-immunoprecipitation, ubiquitination assays, in vitro interaction studies in Drosophila and human cells","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying complex, ubiquitination assays identifying RAD6/MDM2 as the E2/E3 machinery, single lab","pmids":["26336826"],"is_preprint":false},{"year":2016,"finding":"In reconstituted human systems, MutSα inhibits CAF-1- and ASF1A-H3-H4-dependent packaging of a DNA mismatch into a tetrasome, supporting that MMR occurs before mismatch packaging into the tetrasome. Additionally, CAF-1- and ASF1A-H3-H4-dependent deposition of histone (H3-H4)2 tetramers suppresses unnecessary degradation of the discontinuous strand during MMR reactions.","method":"Reconstituted in vitro systems with purified human proteins (MMR, CAF-1, ASF1A-H3-H4), tetrasome deposition assays, strand degradation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — fully reconstituted in vitro system with purified components testing multiple functional interactions, single lab","pmids":["26945061"],"is_preprint":false},{"year":2016,"finding":"sNASP contains at least two histone interaction sites, beyond the TPR-H3 peptide site that overlaps the ASF1A-H3-H4 interface, that are compatible with simultaneous ASF1A binding, allowing sNASP and ASF1A to form a quaternary complex with H3-H4. sNASP makes a specific complex with H3 alone in vitro (but not H4), suggesting it acts upstream of ASF1A in the nucleosome assembly pathway. Together, sNASP and ASF1A can fold an H3-H4 dimer in vitro.","method":"In vitro binding assays, pull-down, analytical biochemistry, reconstitution of H3-H4 folding in vitro","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution demonstrating quaternary complex, H3-H4 folding assay, multiple orthogonal binding measurements, single lab","pmids":["28123037"],"is_preprint":false},{"year":2016,"finding":"ASF1a associates with the acetyltransferase CBP and promotes H3K56 acetylation at the Ifnb promoter following VSV infection in macrophages, thereby enhancing IFN-β production. ASF1a is induced in VSV-infected macrophages in an IRF3-dependent manner.","method":"Co-immunoprecipitation, chromatin immunoprecipitation, siRNA knockdown, IFN-β production assays in macrophages","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying ASF1a-CBP complex, ChIP confirming H3K56ac at Ifnb promoter, knockdown with functional IFN-β readout, single lab","pmids":["27596240"],"is_preprint":false},{"year":2017,"finding":"ASF1a interacts with MDC1 and is recruited to sites of DSBs, where it facilitates the interaction of phospho-ATM with MDC1 and phosphorylation of MDC1. This enables recruitment of RNF8/RNF168 ubiquitin ligases, histone ubiquitination, 53BP1 recruitment, and NHEJ. ASF1a deficiency reduces NHEJ and sensitizes cells to DSBs. This role is specific to ASF1a (not ASF1b) and does not require its histone chaperone activity.","method":"Co-immunoprecipitation, siRNA knockdown, ChIP, NHEJ assays, γ-H2AX foci, 53BP1 foci, DSB sensitivity assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, multiple knockdown phenotypes, pathway epistasis, specificity demonstrated by ASF1b comparison and chaperone-dead mutant, single rigorous study with multiple orthogonal methods","pmids":["28943310"],"is_preprint":false},{"year":2018,"finding":"USP52 is a bona fide deubiquitinase that physically associates with ASF1A and promotes ASF1A deubiquitination and stabilization, thereby facilitating chromatin assembly and cell cycle progression. USP52-promoted ASF1A stabilization sensitizes cells to DNA damage when impaired.","method":"Co-immunoprecipitation, in vitro deubiquitinase assay, ubiquitination assays, siRNA knockdown, overexpression studies in breast cancer cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro deubiquitinase activity assay demonstrating enzymatic activity, Co-IP identifying complex, multiple functional readouts, single lab with multiple orthogonal methods","pmids":["29599486"],"is_preprint":false},{"year":2018,"finding":"Asf1a is recruited to bivalent chromatin promoters (partially through association with transcription factors) and mediates nucleosome disassembly during ES cell differentiation. The Asf1a-histone interaction (not nucleosome assembly activity) is required for resolution of bivalent domains and activation of lineage-specific genes. Deletion of Asf1a compromises lineage-specific gene expression but does not affect silencing of pluripotent genes.","method":"CRISPR deletion, chromatin immunoprecipitation, nucleosome disassembly assays, gene expression analysis, domain-specific mutants in mouse ES cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic deletion with defined molecular mechanism, mutant separation of function (histone interaction vs. assembly), ChIP for bivalent domain resolution, single rigorous study","pmids":["29915027"],"is_preprint":false},{"year":2019,"finding":"ASF1a inhibition in tumor cells induces immunogenic macrophage differentiation in the tumor microenvironment by upregulating GM-CSF expression, and potentiates T-cell activation in combination with anti-PD-1 therapy in KRAS-mutant lung adenocarcinoma.","method":"In vivo CRISPR screen, genetic deletion (CRISPR KO), tumor microenvironment analysis, cytokine measurement (GM-CSF), immune cell phenotyping","journal":"Cancer discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo CRISPR screen followed by mechanistic validation including GM-CSF measurement, macrophage phenotyping, single lab","pmids":["31744829"],"is_preprint":false},{"year":2019,"finding":"ASF1a inhibition in cancer cells with wild-type p53 induces widespread DNA damage, leading to robust upregulation of p53 and p21cip1 expression and cellular senescence. p53 inhibition attenuates the p21cip1 induction caused by ASF1a depletion, placing ASF1a upstream of the p53-p21 axis.","method":"siRNA knockdown, DNA damage markers (γ-H2AX), flow cytometry for senescence, p53 inhibitor epistasis, Western blotting in HCC and prostate cancer cells","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with defined molecular pathway (p53 inhibitor epistasis), multiple cancer cell lines, single lab","pmids":["30692519"],"is_preprint":false},{"year":2021,"finding":"Chk1, activated by ATM kinase at DNA breaks in G1, directly phosphorylates ASF1A at Ser-166. ASF1A phosphorylated at Ser-166 interacts with MDC1, enhancing MDC1's interaction with ATM and stable ATM localization at DSBs. This promotes downstream histone ubiquitination, 53BP1 recruitment, and NHEJ in G1. This role of ASF1A in NHEJ is independent of its histone chaperone activity.","method":"In vitro kinase assay, phospho-specific antibody, Co-immunoprecipitation, siRNA knockdown, NHEJ assays, 53BP1/γ-H2AX foci in G1-arrested cells","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay directly demonstrating Chk1 phosphorylation of ASF1A-Ser166, Co-IP showing phospho-dependent MDC1 interaction, epistasis with Chk1 deficiency, multiple orthogonal methods","pmids":["33503415"],"is_preprint":false},{"year":2021,"finding":"Asf1a, but not Asf1b, is required for assembly of histone H3.3 in paternal pronuclei after fertilization in mice. Asf1a knockdown severely reduces H3K56 acetylation levels and Oct4 expression in blastocyst-stage embryos. Both Asf1a and Asf1b are required for pre-implantation embryonic development, but through distinct mechanisms.","method":"Morpholino knockdown, immunofluorescence for H3.3, H3K56ac, Oct4 and PCNA in mouse embryos","journal":"Epigenetics & chromatin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with defined molecular phenotypes (H3.3 assembly, H3K56ac, Oct4), comparative Asf1a vs. Asf1b dissection, single lab","pmids":["34906203"],"is_preprint":false},{"year":2022,"finding":"ASF1A acts as a coactivator of the Notch transcriptional complex, inducing H3K56ac modification at promoters of Notch target genes and enhancing RBPJ binding to these promoters, thereby activating Notch signaling and mediating differentiation arrest in CML blast crisis cells.","method":"Co-immunoprecipitation, ChIP for H3K56ac and RBPJ, siRNA/shRNA knockdown, in vivo CML model, gene expression analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying ASF1A-Notch complex, ChIP for H3K56ac at Notch target promoters, in vivo validation, single lab","pmids":["36184659"],"is_preprint":false},{"year":2024,"finding":"ASF1A was identified as a cofactor of the acetyltransferase P300 that precisely regulates the enrichment of H3K18 lactylation (H3K18la) at the SNAI1 promoter, thereby activating SNAI1 transcription and promoting endothelial-to-mesenchymal transition (EndMT) in atherosclerosis. Endothelium-specific ASF1A deletion inhibited EndMT and alleviated atherosclerosis in Apoe KO mice.","method":"Co-immunoprecipitation (ASF1A-P300 complex), ChIP for H3K18la at SNAI1 promoter, endothelial-specific Asf1a knockout mouse model (Apoe KO Asf1a ECKO), in vitro EndMT assays","journal":"Acta pharmaceutica Sinica. B","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP identifying ASF1A-P300 complex, ChIP defining chromatin target, in vivo mouse KO with quantitative atherosclerosis phenotype, multiple orthogonal methods in single study","pmids":["39027248"],"is_preprint":false},{"year":2024,"finding":"Cryo-EM structure of the CODANIN-1 (CDAN1)–ASF1A complex at 3.75 Å resolution reveals that CDAN1 forms a dimer where each monomer holds two ASF1 molecules using two B-domains and two histone H3 mimic helices (HMHs). Interaction via the HMH and B-domains blocks formation of the ASF1/H3-H4 complex and sequesters ASF1A in the cytoplasm, inhibiting nucleosome assembly.","method":"Single-particle cryo-EM, biochemical reconstitution, binding assays","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with biochemical validation of inhibitory mechanism, two independent preprint studies reporting concordant findings","pmids":[],"is_preprint":true},{"year":2024,"finding":"CDAN1 dimerizes and forms cytosolic complexes with CDIN1 and multiple copies of ASF1A/B. Cryo-EM structures show CDAN1 engages ASF1 via two B-domains and two helices that mimic histone H3 binding, allowing one CDAN1 to recruit two ASF1 molecules. ASF1A and ASF1B have different requirements for CDAN1 engagement. This sequesters and inhibits ASF1A chaperone function.","method":"Single-particle cryo-EM, biochemical reconstitution, in vitro binding assays, comparative ASF1A vs ASF1B analysis","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure plus biochemical reconstitution demonstrating mechanistic inhibition, concordant with independent parallel preprint","pmids":[],"is_preprint":true},{"year":2025,"finding":"ASF1a (as part of the HIRA complex) fails to localize to PML nuclear bodies in Sp100 knockout keratinocytes even after interferon stimulation. The Sp100A isoform (via its SUMO-interacting motif) is the primary driver of HIRA/UBN1/ASF1a complex localization to PML-NBs.","method":"CRISPR-Cas9 Sp100 knockout, immunofluorescence for HIRA/UBN1/ASF1a at PML-NBs, isoform-specific rescue experiments","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with defined localization phenotype, isoform-specific rescue, single preprint study","pmids":[],"is_preprint":true}],"current_model":"ASF1A is a histone H3-H4 chaperone that functions in multiple chromatin contexts: it forms the quaternary HIRA/UBN1/CABIN1/ASF1a (HUCA) complex (where HIRA acts as scaffold) to deposit histone H3.3 in a replication-independent manner and drive SAHF formation and cellular senescence; it acts in DNA double-strand break repair by facilitating ATM-mediated phosphorylation of MDC1 (a role independent of its chaperone activity, promoted by Chk1-mediated phosphorylation at Ser-166) to enable NHEJ; it is regulated by ubiquitin-mediated degradation (via RAD6/MDM2 for degradation and USP52 for stabilization, as well as ATR/CRL1βTRCP-dependent degradation at stalled replication forks); its interaction with downstream chaperones and histones is competitively blocked by CDAN1, which sequesters ASF1A in the cytoplasm via B-domain and histone H3 mimic helix contacts; and it mediates transcriptional regulation by acting as a coactivator for P300-dependent H3K18 lactylation at gene promoters and for the Notch transcriptional complex via H3K56 acetylation."},"narrative":{"mechanistic_narrative":"ASF1A is a histone H3-H4 chaperone that operates across replication-independent chromatin assembly, DNA damage signaling, and transcriptional regulation [PMID:21807893, PMID:28943310]. In its core assembly role, ASF1A is a member of the HIRA/UBN1/CABIN1/ASF1a (HUCA) quaternary complex in which HIRA serves as scaffold to assemble UBN1, CABIN1, and ASF1a for replication-independent deposition of histone variant H3.3 [PMID:19029251, PMID:21807893]; this complex is rate-limiting for senescence-associated heterochromatin foci (SAHF) and senescence-associated cell-cycle exit, and HIRA's transit through PML nuclear bodies is required for SAHF formation [PMID:15621527, PMID:17242198]. Structurally, HIRA binds the ASF1a beta-sandwich through an antiparallel B-domain beta-hairpin, and CAF-1 p60 uses B-domain-like motifs to compete for the same surface, making downstream-chaperone engagement mutually exclusive [PMID:16980972]; in nucleosome assembly ASF1a acts with sNASP, which positions H3 upstream and forms a quaternary complex that folds the H3-H4 dimer [PMID:28123037]. The chaperone surface is competitively occupied and inhibited by CODANIN-1 (CDAN1), which engages ASF1A via B-domains and histone H3 mimic helices, blocking ASF1/H3-H4 complex formation and sequestering ASF1A in the cytoplasm. Beyond assembly, ASF1A has a chaperone-independent role in DNA double-strand break repair: it is recruited to breaks, interacts with MDC1, and facilitates ATM-mediated MDC1 phosphorylation to drive RNF8/RNF168-dependent histone ubiquitination, 53BP1 recruitment, and NHEJ, a function specific to ASF1a over ASF1b and promoted by Chk1-mediated phosphorylation at Ser-166 [PMID:28943310, PMID:33503415]. ASF1A protein levels are set by ubiquitin-dependent turnover, opposed by USP52-mediated deubiquitination and stabilization, and by ATR/CRL1(βTRCP)-dependent degradation at stalled replication forks [PMID:29599486, PMID:24700029]. As a transcriptional coactivator, ASF1A promotes H3K56 acetylation at Notch target promoters to enhance RBPJ binding and cooperates with P300 to regulate H3K18 lactylation, while in development its histone-interaction activity resolves bivalent chromatin domains during ES-cell differentiation and assembles H3.3 in the paternal pronucleus [PMID:36184659, PMID:39027248, PMID:29915027, PMID:34906203].","teleology":[{"year":2005,"claim":"Established that ASF1a physically partners with HIRA and that this complex is rate-limiting for forming senescence-associated heterochromatin and driving senescence cell-cycle exit, defining ASF1a's role in replication-independent chromatin remodeling.","evidence":"Co-IP, dominant-negative mutants, and siRNA with colocalization in primary human cells approaching senescence","pmids":["15621527"],"confidence":"High","gaps":["Did not define the full subunit composition of the complex","Mechanism of HIRA entry into PML bodies left open"]},{"year":2006,"claim":"Resolved the structural basis of ASF1a partner selection, showing the HIRA B-domain and CAF-1 p60 compete for the same beta-sandwich surface, explaining mutually exclusive downstream-chaperone routing.","evidence":"X-ray crystallography of the ASF1a-HIRA heterodimer with biochemical competition and mutagenesis","pmids":["16980972"],"confidence":"High","gaps":["No structure of the full quaternary complex","Determinants of ASF1a vs ASF1b differential affinity only partly mapped"]},{"year":2008,"claim":"Identified UBN1 as a direct HIRA-binding component of the complex linked to H3K9 methyltransferase activity at repressed genes, extending the senescence assembly machinery beyond ASF1a and HIRA.","evidence":"Co-IP, recombinant protein binding, siRNA, and ChIP","pmids":["19029251"],"confidence":"High","gaps":["How UBN1 directs histone deposition versus methyltransferase recruitment unresolved"]},{"year":2011,"claim":"Completed the HUCA quaternary complex by adding CABIN1 with HIRA as scaffold and showed it preferentially deposits H3.3 in a replication-independent manner; parallel work placed the HIRA/ASF1a pathway alongside pRB and p53 in SAHF formation and dissected HIRA-specific roles in ALT bodies.","evidence":"Reconstitution from recombinant proteins, endogenous Co-IP, epistasis analysis, and comparative HIRA vs ASF1a knockdown in senescent and ALT cells","pmids":["21807893","17242198","21347226"],"confidence":"High","gaps":["Stoichiometry and assembly order within HUCA not fully defined","ASF1a contribution to H3.3 deposition separable from HIRA only partially addressed"]},{"year":2011,"claim":"Linked ASF1a to recovery from the DNA damage checkpoint by showing it restores H3K56 acetylation after UV repair, enabling γ-H2AX dephosphorylation, while leaving repair itself ASF1a-independent.","evidence":"siRNA, ChIP, and γ-H2AX immunofluorescence in UV-irradiated human cells","pmids":["21727091"],"confidence":"Medium","gaps":["Acetyltransferase responsible for H3K56Ac restoration not identified here","Mechanistic coupling of H3K56Ac to phosphatase activity unclear"]},{"year":2012,"claim":"Extended ASF1a's chaperone function to host-pathogen chromatin, showing it assembles chromatin on incoming HSV-1 DNA to restrain immediate-early transcription and viral replication.","evidence":"siRNA, MNase protection, RT-PCR, and viral growth assays in HeLa cells","pmids":["22951827"],"confidence":"Medium","gaps":["Which downstream chaperone partner deposits histones on viral DNA not defined","Direct vs indirect effect on IE transcription not separated"]},{"year":2013,"claim":"Provided the evolutionary and biochemical basis for ASF1a/ASF1b subfunctionalization, mapping N- and C-terminal regions outside the H3-H4 surface as determinants of preferential downstream-chaperone partnering.","evidence":"Biochemical binding assays, evolutionary and structural comparison","pmids":["23645555"],"confidence":"Medium","gaps":["Functional consequences of MCM9-intronic genomic relocation not tested in cells"]},{"year":2014,"claim":"Defined two layers of ASF1A regulation and function: ATR/CRL1(βTRCP)-mediated degradation that drives dechromatinization at stalled forks, and an essential requirement for reprogramming somatic cells to pluripotency.","evidence":"Ubiquitination assays with ATR/CRL1βTRCP perturbation; oocyte localization plus loss/gain-of-function reprogramming assays","pmids":["24700029","25035411"],"confidence":"Medium","gaps":["Whether dechromatinization is purely degradation-driven or also active not resolved","Molecular target genes reprogrammed by ASF1A not mapped"]},{"year":2015,"claim":"Identified the degradation machinery for ASF1A, showing the conserved E2 RAD6 cooperates with E3 MDM2 to drive ubiquitin-proteasome turnover.","evidence":"Co-IP, in vitro interaction, and ubiquitination assays in Drosophila and human cells","pmids":["26336826"],"confidence":"Medium","gaps":["Ubiquitination site(s) on ASF1A not mapped","Signals triggering RAD6/MDM2-dependent turnover unknown"]},{"year":2016,"claim":"Placed ASF1A within reconstituted mismatch repair and the upstream folding pathway, showing CAF-1/ASF1A-H3-H4 deposition is gated by MutSα and that sNASP and ASF1A together fold the H3-H4 dimer; in parallel ASF1a was tied to innate immunity via CBP-dependent H3K56ac at the Ifnb promoter.","evidence":"Fully reconstituted in vitro MMR and tetrasome assays; in vitro H3-H4 folding/binding assays; Co-IP, ChIP, and IFN-β assays in macrophages","pmids":["26945061","28123037","27596240"],"confidence":"High","gaps":["In vivo relevance of MMR-coupled tetrasome deposition not shown","Whether sNASP-ASF1A folding feeds all downstream chaperones untested"]},{"year":2017,"claim":"Revealed a chaperone-independent role for ASF1a in NHEJ, where it recruits to DSBs and promotes ATM-mediated MDC1 phosphorylation to trigger RNF8/RNF168 ubiquitination and 53BP1 recruitment, with specificity over ASF1b.","evidence":"Reciprocal Co-IP, siRNA, ChIP, NHEJ assays, foci analysis, and chaperone-dead mutant in human cells","pmids":["28943310"],"confidence":"High","gaps":["How ASF1a is recruited to breaks not fully defined here","Structural basis of ASF1a-MDC1 interaction unknown"]},{"year":2018,"claim":"Identified USP52 as the deubiquitinase opposing ASF1A turnover, stabilizing it to support chromatin assembly and cell-cycle progression, and separately established that ASF1a histone-interaction activity resolves bivalent chromatin during ES-cell differentiation.","evidence":"In vitro DUB assay, Co-IP, ubiquitination assays in breast cancer cells; CRISPR deletion, ChIP, and domain-specific mutants in mouse ES cells","pmids":["29599486","29915027"],"confidence":"High","gaps":["Transcription factors recruiting ASF1a to bivalent promoters only partly identified","Balance between USP52 and RAD6/MDM2 in setting ASF1A levels not quantified"]},{"year":2019,"claim":"Linked ASF1A loss to anti-tumor outcomes, showing its inhibition triggers p53-p21-dependent senescence in WT-p53 cancers and reprograms the tumor microenvironment toward immunogenic macrophages, synergizing with anti-PD-1.","evidence":"siRNA with p53-inhibitor epistasis and DNA damage markers; in vivo CRISPR screen, KO, and immune phenotyping in KRAS-mutant lung adenocarcinoma","pmids":["30692519","31744829"],"confidence":"Medium","gaps":["Direct cause of DNA damage upon ASF1A loss not pinpointed","Mechanism connecting ASF1A loss to GM-CSF upregulation undefined"]},{"year":2021,"claim":"Defined the kinase signaling that activates ASF1A's NHEJ role, showing Chk1 (downstream of ATM) directly phosphorylates Ser-166 to enable the MDC1-ATM interaction in G1, and established ASF1a-specific H3.3 assembly in the paternal pronucleus.","evidence":"In vitro kinase assay, phospho-specific antibody, Co-IP, and NHEJ/foci assays in G1-arrested cells; morpholino knockdown with immunofluorescence in mouse embryos","pmids":["33503415","34906203"],"confidence":"High","gaps":["Whether Ser-166 phosphorylation affects chaperone roles untested","Distinct mechanisms of Asf1a vs Asf1b in embryogenesis only partly resolved"]},{"year":2022,"claim":"Established ASF1A as a transcriptional coactivator for Notch, depositing H3K56ac at target promoters to enhance RBPJ binding and enforce differentiation arrest in CML blast crisis.","evidence":"Co-IP, ChIP for H3K56ac and RBPJ, knockdown, and in vivo CML model","pmids":["36184659"],"confidence":"Medium","gaps":["Acetyltransferase recruited by ASF1A at Notch promoters not identified","Direct ASF1A-RBPJ contacts not mapped"]},{"year":2024,"claim":"Expanded ASF1A coactivator function to histone lactylation and resolved the structural basis of its inhibition, showing ASF1A partners P300 to regulate H3K18la at SNAI1 driving EndMT in atherosclerosis, while CDAN1 sequesters ASF1A in the cytoplasm via B-domains and H3 mimic helices to block H3-H4 binding.","evidence":"Co-IP, ChIP for H3K18la, endothelial-specific Asf1a KO in Apoe-null mice; cryo-EM of the CDAN1-ASF1A complex with biochemical reconstitution (preprint)","pmids":["39027248"],"confidence":"High","gaps":["How P300 and ASF1A jointly select lactylation targets unclear","Cellular triggers controlling CDAN1-mediated cytoplasmic sequestration undefined"]},{"year":2025,"claim":"Identified Sp100A as the driver of HUCA complex targeting to PML nuclear bodies, connecting an upstream localization determinant to ASF1a's senescence-associated chromatin functions.","evidence":"CRISPR Sp100 knockout with immunofluorescence and isoform-specific rescue in keratinocytes (preprint)","pmids":[],"confidence":"Medium","gaps":["Single preprint not independently confirmed","Functional consequence of failed PML-NB localization for SAHF not tested here"]},{"year":null,"claim":"How ASF1A's multiple roles — H3.3/H3-H4 chaperoning, chaperone-independent NHEJ signaling, and transcriptional coactivation via distinct histone modifications — are coordinately partitioned within a single cell and switched between contexts remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating chaperone vs non-chaperone functions","Determinants directing ASF1A to assembly vs repair vs transcription unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[5,13,17,1]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[22,23,17]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[15,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5,15]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[24,25]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[15,20]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[5,3,17]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[15,20,12]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[22,23,17]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,19]}],"complexes":["HUCA (HIRA/UBN1/CABIN1/ASF1a)","CDAN1-ASF1A complex"],"partners":["HIRA","UBN1","CABIN1","CDAN1","MDC1","USP52","RAD6","EP300"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y294","full_name":"Histone chaperone ASF1A","aliases":["Anti-silencing function protein 1 homolog A","hAsf1","hAsf1a","CCG1-interacting factor A","CIA","hCIA"],"length_aa":204,"mass_kda":23.0,"function":"Histone chaperone that facilitates histone deposition and histone exchange and removal during nucleosome assembly and disassembly (PubMed:10759893, PubMed:11897662, PubMed:12842904, PubMed:14718166, PubMed:15664198, PubMed:16151251, PubMed:21454524). Cooperates with chromatin assembly factor 1 (CAF-1) to promote replication-dependent chromatin assembly and with HIRA to promote replication-independent chromatin assembly (PubMed:11897662, PubMed:14718166, PubMed:15664198). Promotes homologous recombination-mediated repair of double-strand breaks (DSBs) at stalled or collapsed replication forks: acts by mediating histone replacement at DSBs, leading to recruitment of the MMS22L-TONSL complex and subsequent loading of RAD51 (PubMed:29478807). Also involved in the nuclear import of the histone H3-H4 dimer together with importin-4 (IPO4): specifically recognizes and binds newly synthesized histones with the monomethylation of H3 'Lys-9' and acetylation at 'Lys-14' (H3K9me1K14ac) marks, and diacetylation at 'Lys-5' and 'Lys-12' of H4 (H4K5K12ac) marks in the cytosol (PubMed:21454524, PubMed:29408485). Required for the formation of senescence-associated heterochromatin foci (SAHF) and efficient senescence-associated cell cycle exit (PubMed:15621527)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9Y294/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ASF1A","classification":"Not Classified","n_dependent_lines":136,"n_total_lines":1208,"dependency_fraction":0.11258278145695365},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALD1","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CTTN","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ASF1A","total_profiled":1310},"omim":[{"mim_id":"615614","title":"MMS22-LIKE PROTEIN; MMS22L","url":"https://www.omim.org/entry/615614"},{"mim_id":"613841","title":"UBINUCLEIN 2; UBN2","url":"https://www.omim.org/entry/613841"},{"mim_id":"609771","title":"UBINUCLEIN 1; UBN1","url":"https://www.omim.org/entry/609771"},{"mim_id":"609190","title":"ANTI-SILENCING FUNCTION 1B HISTONE CHAPERONE; ASF1B","url":"https://www.omim.org/entry/609190"},{"mim_id":"609189","title":"ANTI-SILENCING FUNCTION 1A HISTONE CHAPERONE; ASF1A","url":"https://www.omim.org/entry/609189"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ASF1A"},"hgnc":{"alias_symbol":["DKFZP547E2110","CIA"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y294","domains":[{"cath_id":"2.60.40.1490","chopping":"3-147","consensus_level":"high","plddt":96.5988,"start":3,"end":147}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y294","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y294-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y294-F1-predicted_aligned_error_v6.png","plddt_mean":84.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ASF1A","jax_strain_url":"https://www.jax.org/strain/search?query=ASF1A"},"sequence":{"accession":"Q9Y294","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y294.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y294/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y294"}},"corpus_meta":[{"pmid":"15621527","id":"PMC_15621527","title":"Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA.","date":"2005","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/15621527","citation_count":556,"is_preprint":false},{"pmid":"31744829","id":"PMC_31744829","title":"In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma.","date":"2019","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/31744829","citation_count":181,"is_preprint":false},{"pmid":"16980972","id":"PMC_16980972","title":"Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly.","date":"2006","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16980972","citation_count":158,"is_preprint":false},{"pmid":"17242198","id":"PMC_17242198","title":"Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17242198","citation_count":128,"is_preprint":false},{"pmid":"19029251","id":"PMC_19029251","title":"Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19029251","citation_count":104,"is_preprint":false},{"pmid":"21807893","id":"PMC_21807893","title":"Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21807893","citation_count":90,"is_preprint":false},{"pmid":"39027248","id":"PMC_39027248","title":"ASF1A-dependent P300-mediated histone H3 lysine 18 lactylation promotes atherosclerosis by regulating EndMT.","date":"2024","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/39027248","citation_count":88,"is_preprint":false},{"pmid":"25035411","id":"PMC_25035411","title":"Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25035411","citation_count":68,"is_preprint":false},{"pmid":"31914881","id":"PMC_31914881","title":"LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31914881","citation_count":67,"is_preprint":false},{"pmid":"21727091","id":"PMC_21727091","title":"ASF1A and ATM regulate H3K56-mediated cell-cycle checkpoint recovery in response to UV irradiation.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21727091","citation_count":59,"is_preprint":false},{"pmid":"23645555","id":"PMC_23645555","title":"Subfunctionalization via adaptive evolution influenced by genomic context: the case of histone chaperones ASF1a and ASF1b.","date":"2013","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/23645555","citation_count":55,"is_preprint":false},{"pmid":"22941664","id":"PMC_22941664","title":"Cell-cycle-regulated control of VSG expression site silencing by histones and histone chaperones ASF1A and CAF-1b in Trypanosoma brucei.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22941664","citation_count":52,"is_preprint":false},{"pmid":"29599486","id":"PMC_29599486","title":"USP52 acts as a deubiquitinase and promotes histone chaperone ASF1A stabilization.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29599486","citation_count":42,"is_preprint":false},{"pmid":"22247756","id":"PMC_22247756","title":"Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7R.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22247756","citation_count":39,"is_preprint":false},{"pmid":"28943310","id":"PMC_28943310","title":"ASF1a Promotes Non-homologous End Joining Repair by Facilitating Phosphorylation of MDC1 by ATM at Double-Strand Breaks.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28943310","citation_count":35,"is_preprint":false},{"pmid":"22401310","id":"PMC_22401310","title":"Identification of an ubinuclein 1 region required for stability and function of the human HIRA/UBN1/CABIN1/ASF1a histone H3.3 chaperone complex.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22401310","citation_count":32,"is_preprint":false},{"pmid":"30692519","id":"PMC_30692519","title":"ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30692519","citation_count":29,"is_preprint":false},{"pmid":"26945061","id":"PMC_26945061","title":"DNA Mismatch Repair Interacts with CAF-1- and ASF1A-H3-H4-dependent Histone (H3-H4)2 Tetramer Deposition.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26945061","citation_count":29,"is_preprint":false},{"pmid":"29915027","id":"PMC_29915027","title":"Asf1a resolves bivalent chromatin domains for the induction of lineage-specific genes during mouse embryonic stem cell differentiation.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29915027","citation_count":27,"is_preprint":false},{"pmid":"24700029","id":"PMC_24700029","title":"ATR checkpoint kinase and CRL1βTRCP collaborate to degrade ASF1a and thus repress genes overlapping with clusters of stalled replication forks.","date":"2014","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24700029","citation_count":26,"is_preprint":false},{"pmid":"21347226","id":"PMC_21347226","title":"HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21347226","citation_count":26,"is_preprint":false},{"pmid":"22951827","id":"PMC_22951827","title":"Chromatin assembly on herpes simplex virus 1 DNA early during a lytic infection is Asf1a dependent.","date":"2012","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/22951827","citation_count":25,"is_preprint":false},{"pmid":"28123037","id":"PMC_28123037","title":"sNASP and ASF1A function through both competitive and compatible modes of histone binding.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28123037","citation_count":23,"is_preprint":false},{"pmid":"26336826","id":"PMC_26336826","title":"A conserved RAD6-MDM2 ubiquitin ligase machinery targets histone chaperone ASF1A in tumorigenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26336826","citation_count":14,"is_preprint":false},{"pmid":"33503415","id":"PMC_33503415","title":"Chk1 promotes non-homologous end joining in G1 through direct phosphorylation of ASF1A.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33503415","citation_count":12,"is_preprint":false},{"pmid":"32222456","id":"PMC_32222456","title":"Small-molecule arone protects from neuroinflammation in LPS-activated microglia BV-2 cells by targeting histone-remodeling chaperone ASF1a.","date":"2020","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32222456","citation_count":11,"is_preprint":false},{"pmid":"34906203","id":"PMC_34906203","title":"Distinct role of histone chaperone Asf1a and Asf1b during fertilization and pre-implantation embryonic development in mice.","date":"2021","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/34906203","citation_count":10,"is_preprint":false},{"pmid":"36184659","id":"PMC_36184659","title":"Histone chaperone ASF1A accelerates chronic myeloid leukemia blast crisis by activating Notch signaling.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36184659","citation_count":8,"is_preprint":false},{"pmid":"27596240","id":"PMC_27596240","title":"ASF1a enhances antiviral immune response by associating with CBP to mediate acetylation of H3K56 at the Ifnb promoter.","date":"2016","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27596240","citation_count":8,"is_preprint":false},{"pmid":"26580119","id":"PMC_26580119","title":"Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells.","date":"2015","source":"Cellular reprogramming","url":"https://pubmed.ncbi.nlm.nih.gov/26580119","citation_count":7,"is_preprint":false},{"pmid":"31286799","id":"PMC_31286799","title":"ASF1A regulates H4Y72 phosphorylation and promotes autophagy in colon cancer cells via a kinase activity.","date":"2019","source":"Artificial cells, nanomedicine, and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31286799","citation_count":5,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.06.641437","title":"Sp100A isoform promotes HIRA histone chaperone localization to PML nuclear bodies","date":"2025-03-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.06.641437","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.10.602876","title":"CODANIN-1 sequesters ASF1 by using a histone H3 mimic helix to regulate the histone supply","date":"2024-07-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.10.602876","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.08.607204","title":"Mechanism of ASF1 Inhibition by CDAN1","date":"2024-08-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.08.607204","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17929,"output_tokens":7209,"usd":0.080961,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16400,"output_tokens":6067,"usd":0.116837,"stage2_stop_reason":"end_turn"},"total_usd":0.197798,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"ASF1a forms a physical complex with HIRA that is rate-limiting for formation of macroH2A-containing senescence-associated heterochromatin foci (SAHF) and onset of senescence-associated cell cycle exit. As cells approach senescence, HIRA enters PML nuclear bodies where it transiently colocalizes with HP1 proteins prior to HP1 incorporation into SAHF; ASF1a is required for efficient SAHF formation and senescence-associated cell cycle exit.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative mutants, siRNA knockdown, immunofluorescence/colocalization in primary human cells approaching senescence\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP establishing complex, multiple loss-of-function approaches (dominant-negative and knockdown) with defined cellular phenotypes, replicated in subsequent studies\",\n      \"pmids\": [\"15621527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structure of ASF1a-HIRA heterodimer shows the HIRA B domain forms an antiparallel beta-hairpin binding perpendicular to the beta-sandwich of ASF1a via beta-sheet, salt bridge, and van der Waals contacts. The N- and C-terminal regions of ASF1a and ASF1b determine differential affinity for HIRA. CAF-1 p60 uses B domain-like motifs to competitively bind ASF1a, mutually exclusive with HIRA binding.\",\n      \"method\": \"X-ray crystallography, biochemical binding assays, mutational analysis\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and biochemical competition assays in a single rigorous study\",\n      \"pmids\": [\"16980972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HIRA/ASF1a pathway cooperates with pRB and p53 in parallel to form SAHF; the HIRA/ASF1a and pRB pathways converge through the DNAJ-domain protein DNAJA2. HIRA's localization to PML bodies is required for SAHF formation, but this translocation occurs independently of functional pRB and p53.\",\n      \"method\": \"Dominant-negative HIRA mutants, PML-RARα disruption of PML bodies, epistasis analysis, co-immunoprecipitation in primary human cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple loss-of-function approaches and defined pathway placement, replicated across multiple senescence triggers\",\n      \"pmids\": [\"17242198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UBN1 (human ortholog of yeast Hpc2p) is a component of the HIRA/ASF1a chromatin-remodeling complex. The Hpc2-related domain (HRD) of UBN1 directly interacts with the N-terminal WD repeats of HIRA. UBN1 is indispensable for SAHF formation and associates with histone H3K9 methyltransferase activity at proliferation-promoting genes repressed in senescence.\",\n      \"method\": \"Co-immunoprecipitation, direct binding assays with recombinant proteins, siRNA knockdown, chromatin immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, direct recombinant protein binding, knockdown with defined SAHF phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"19029251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ASF1a is required for post-UV-repair restoration of H3K56 acetylation (H3K56Ac), which in turn is needed for dephosphorylation of γ-H2AX and cellular recovery from checkpoint arrest. ATM checkpoint kinase regulates H3K56Ac restoration. Completion of DNA damage repair itself is not dependent on ASF1a or H3K56Ac.\",\n      \"method\": \"siRNA knockdown, chromatin immunoprecipitation, immunofluorescence for γ-H2AX in UV-irradiated human cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockdown with defined molecular phenotype (H3K56Ac, γ-H2AX), single lab with multiple orthogonal readouts\",\n      \"pmids\": [\"21727091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CABIN1 is a functional fourth member of the human HIRA/UBN1/ASF1a (HUCA) quaternary complex. HIRA acts as a scaffold to assemble UBN1, ASF1a, and CABIN1. The HUCA complex preferentially deposits histone variant H3.3 into chromatin in a DNA replication-independent manner, and CABIN1 is involved in heterochromatinization of senescent cells.\",\n      \"method\": \"Co-immunoprecipitation at endogenous and ectopic expression levels, reconstitution of quaternary complex from recombinant proteins, mutational analysis, chromatin fractionation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quaternary complex reconstituted from recombinant proteins, corroborated by endogenous Co-IP and mutational analysis, multiple orthogonal methods\",\n      \"pmids\": [\"21807893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HIRA, but not ASF1a, is required for HP1-mediated formation of ALT-associated PML bodies (APBs) and large HP1 foci following p53/p21 pathway activation in ALT cells. HIRA and ASF1a co-localize inside PML bodies in normal fibroblasts approaching senescence, confirming a senescence-associated ASF1a/HIRA complex inside PML bodies.\",\n      \"method\": \"siRNA knockdown of HIRA vs. ASF1a, immunofluorescence, colocalization in ALT cells and normal fibroblasts\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — comparative knockdown of HIRA vs ASF1a dissecting pathway contributions, single lab with clear positive vs. negative functional outcomes\",\n      \"pmids\": [\"21347226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ASF1a is required for chromatin assembly onto incoming herpes simplex virus 1 (HSV-1) DNA early during lytic infection. ASF1a knockdown reduced viral DNA protection from MNase digestion, increased transcription of immediate early genes ICP0 and ICP4 at 3 hpi, and decreased viral replication and growth.\",\n      \"method\": \"siRNA knockdown, MNase protection assay, RT-PCR, viral growth assay in HeLa cells\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple orthogonal readouts (MNase, transcription, viral replication), single lab\",\n      \"pmids\": [\"22951827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ASF1a and ASF1b underwent subfunctionalization after vertebrate duplication. Regions outside the primary H3-H4 interaction surface (N- and C-terminal regions) determine preferential interactions of ASF1a versus ASF1b with distinct downstream H3-H4 chaperone complexes. ASF1a was relocated into an intron of MCM9 in tetrapod ancestors, providing a different genomic environment and replication timing context.\",\n      \"method\": \"Biochemical binding assays, evolutionary analysis, structural comparison\",\n      \"journal\": \"Molecular biology and evolution\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical binding assays demonstrating differential interactions, complemented by evolutionary analysis, single study\",\n      \"pmids\": [\"23645555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Doxorubicin activates the ATR checkpoint pathway, which causes CRL1(βTRCP)-dependent ubiquitination and proteasomal degradation of ASF1a, leading to localized dechromatinization and repression of genes overlapping with clusters of stalled replication forks.\",\n      \"method\": \"Western blotting, ubiquitination assays, ATR inhibition and CRL1(βTRCP) dominant-negative studies, chromatin fractionation, gene expression analysis in cancer cells\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pathway components tested (ATR inhibition, proteasome inhibition, CRL1βTRCP dominants), single lab\",\n      \"pmids\": [\"24700029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ASF1A is specifically enriched in the metaphase II human oocyte and is necessary for reprogramming of human adult dermal fibroblasts into iPSCs. Overexpression of ASF1A together with OCT4 in fibroblasts exposed to the oocyte-specific paracrine factor GDF9 is sufficient to reprogram them into pluripotent cells.\",\n      \"method\": \"Immunofluorescence localization, loss-of-function (knockdown), overexpression/reprogramming assay, iPSC characterization\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and gain-of-function reprogramming experiments with pluripotency characterization, single lab\",\n      \"pmids\": [\"25035411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The E2 ubiquitin-conjugating enzyme RAD6 is an evolutionarily conserved interacting protein of ASF1 that cooperates with the E3 ligase MDM2 to promote ubiquitin-proteasome-dependent turnover of ASF1A in human cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, in vitro interaction studies in Drosophila and human cells\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying complex, ubiquitination assays identifying RAD6/MDM2 as the E2/E3 machinery, single lab\",\n      \"pmids\": [\"26336826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In reconstituted human systems, MutSα inhibits CAF-1- and ASF1A-H3-H4-dependent packaging of a DNA mismatch into a tetrasome, supporting that MMR occurs before mismatch packaging into the tetrasome. Additionally, CAF-1- and ASF1A-H3-H4-dependent deposition of histone (H3-H4)2 tetramers suppresses unnecessary degradation of the discontinuous strand during MMR reactions.\",\n      \"method\": \"Reconstituted in vitro systems with purified human proteins (MMR, CAF-1, ASF1A-H3-H4), tetrasome deposition assays, strand degradation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — fully reconstituted in vitro system with purified components testing multiple functional interactions, single lab\",\n      \"pmids\": [\"26945061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"sNASP contains at least two histone interaction sites, beyond the TPR-H3 peptide site that overlaps the ASF1A-H3-H4 interface, that are compatible with simultaneous ASF1A binding, allowing sNASP and ASF1A to form a quaternary complex with H3-H4. sNASP makes a specific complex with H3 alone in vitro (but not H4), suggesting it acts upstream of ASF1A in the nucleosome assembly pathway. Together, sNASP and ASF1A can fold an H3-H4 dimer in vitro.\",\n      \"method\": \"In vitro binding assays, pull-down, analytical biochemistry, reconstitution of H3-H4 folding in vitro\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution demonstrating quaternary complex, H3-H4 folding assay, multiple orthogonal binding measurements, single lab\",\n      \"pmids\": [\"28123037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ASF1a associates with the acetyltransferase CBP and promotes H3K56 acetylation at the Ifnb promoter following VSV infection in macrophages, thereby enhancing IFN-β production. ASF1a is induced in VSV-infected macrophages in an IRF3-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation, siRNA knockdown, IFN-β production assays in macrophages\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying ASF1a-CBP complex, ChIP confirming H3K56ac at Ifnb promoter, knockdown with functional IFN-β readout, single lab\",\n      \"pmids\": [\"27596240\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ASF1a interacts with MDC1 and is recruited to sites of DSBs, where it facilitates the interaction of phospho-ATM with MDC1 and phosphorylation of MDC1. This enables recruitment of RNF8/RNF168 ubiquitin ligases, histone ubiquitination, 53BP1 recruitment, and NHEJ. ASF1a deficiency reduces NHEJ and sensitizes cells to DSBs. This role is specific to ASF1a (not ASF1b) and does not require its histone chaperone activity.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, ChIP, NHEJ assays, γ-H2AX foci, 53BP1 foci, DSB sensitivity assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, multiple knockdown phenotypes, pathway epistasis, specificity demonstrated by ASF1b comparison and chaperone-dead mutant, single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"28943310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"USP52 is a bona fide deubiquitinase that physically associates with ASF1A and promotes ASF1A deubiquitination and stabilization, thereby facilitating chromatin assembly and cell cycle progression. USP52-promoted ASF1A stabilization sensitizes cells to DNA damage when impaired.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitinase assay, ubiquitination assays, siRNA knockdown, overexpression studies in breast cancer cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro deubiquitinase activity assay demonstrating enzymatic activity, Co-IP identifying complex, multiple functional readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29599486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Asf1a is recruited to bivalent chromatin promoters (partially through association with transcription factors) and mediates nucleosome disassembly during ES cell differentiation. The Asf1a-histone interaction (not nucleosome assembly activity) is required for resolution of bivalent domains and activation of lineage-specific genes. Deletion of Asf1a compromises lineage-specific gene expression but does not affect silencing of pluripotent genes.\",\n      \"method\": \"CRISPR deletion, chromatin immunoprecipitation, nucleosome disassembly assays, gene expression analysis, domain-specific mutants in mouse ES cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic deletion with defined molecular mechanism, mutant separation of function (histone interaction vs. assembly), ChIP for bivalent domain resolution, single rigorous study\",\n      \"pmids\": [\"29915027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ASF1a inhibition in tumor cells induces immunogenic macrophage differentiation in the tumor microenvironment by upregulating GM-CSF expression, and potentiates T-cell activation in combination with anti-PD-1 therapy in KRAS-mutant lung adenocarcinoma.\",\n      \"method\": \"In vivo CRISPR screen, genetic deletion (CRISPR KO), tumor microenvironment analysis, cytokine measurement (GM-CSF), immune cell phenotyping\",\n      \"journal\": \"Cancer discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo CRISPR screen followed by mechanistic validation including GM-CSF measurement, macrophage phenotyping, single lab\",\n      \"pmids\": [\"31744829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ASF1a inhibition in cancer cells with wild-type p53 induces widespread DNA damage, leading to robust upregulation of p53 and p21cip1 expression and cellular senescence. p53 inhibition attenuates the p21cip1 induction caused by ASF1a depletion, placing ASF1a upstream of the p53-p21 axis.\",\n      \"method\": \"siRNA knockdown, DNA damage markers (γ-H2AX), flow cytometry for senescence, p53 inhibitor epistasis, Western blotting in HCC and prostate cancer cells\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with defined molecular pathway (p53 inhibitor epistasis), multiple cancer cell lines, single lab\",\n      \"pmids\": [\"30692519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Chk1, activated by ATM kinase at DNA breaks in G1, directly phosphorylates ASF1A at Ser-166. ASF1A phosphorylated at Ser-166 interacts with MDC1, enhancing MDC1's interaction with ATM and stable ATM localization at DSBs. This promotes downstream histone ubiquitination, 53BP1 recruitment, and NHEJ in G1. This role of ASF1A in NHEJ is independent of its histone chaperone activity.\",\n      \"method\": \"In vitro kinase assay, phospho-specific antibody, Co-immunoprecipitation, siRNA knockdown, NHEJ assays, 53BP1/γ-H2AX foci in G1-arrested cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay directly demonstrating Chk1 phosphorylation of ASF1A-Ser166, Co-IP showing phospho-dependent MDC1 interaction, epistasis with Chk1 deficiency, multiple orthogonal methods\",\n      \"pmids\": [\"33503415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Asf1a, but not Asf1b, is required for assembly of histone H3.3 in paternal pronuclei after fertilization in mice. Asf1a knockdown severely reduces H3K56 acetylation levels and Oct4 expression in blastocyst-stage embryos. Both Asf1a and Asf1b are required for pre-implantation embryonic development, but through distinct mechanisms.\",\n      \"method\": \"Morpholino knockdown, immunofluorescence for H3.3, H3K56ac, Oct4 and PCNA in mouse embryos\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with defined molecular phenotypes (H3.3 assembly, H3K56ac, Oct4), comparative Asf1a vs. Asf1b dissection, single lab\",\n      \"pmids\": [\"34906203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ASF1A acts as a coactivator of the Notch transcriptional complex, inducing H3K56ac modification at promoters of Notch target genes and enhancing RBPJ binding to these promoters, thereby activating Notch signaling and mediating differentiation arrest in CML blast crisis cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP for H3K56ac and RBPJ, siRNA/shRNA knockdown, in vivo CML model, gene expression analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying ASF1A-Notch complex, ChIP for H3K56ac at Notch target promoters, in vivo validation, single lab\",\n      \"pmids\": [\"36184659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ASF1A was identified as a cofactor of the acetyltransferase P300 that precisely regulates the enrichment of H3K18 lactylation (H3K18la) at the SNAI1 promoter, thereby activating SNAI1 transcription and promoting endothelial-to-mesenchymal transition (EndMT) in atherosclerosis. Endothelium-specific ASF1A deletion inhibited EndMT and alleviated atherosclerosis in Apoe KO mice.\",\n      \"method\": \"Co-immunoprecipitation (ASF1A-P300 complex), ChIP for H3K18la at SNAI1 promoter, endothelial-specific Asf1a knockout mouse model (Apoe KO Asf1a ECKO), in vitro EndMT assays\",\n      \"journal\": \"Acta pharmaceutica Sinica. B\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP identifying ASF1A-P300 complex, ChIP defining chromatin target, in vivo mouse KO with quantitative atherosclerosis phenotype, multiple orthogonal methods in single study\",\n      \"pmids\": [\"39027248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structure of the CODANIN-1 (CDAN1)–ASF1A complex at 3.75 Å resolution reveals that CDAN1 forms a dimer where each monomer holds two ASF1 molecules using two B-domains and two histone H3 mimic helices (HMHs). Interaction via the HMH and B-domains blocks formation of the ASF1/H3-H4 complex and sequesters ASF1A in the cytoplasm, inhibiting nucleosome assembly.\",\n      \"method\": \"Single-particle cryo-EM, biochemical reconstitution, binding assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with biochemical validation of inhibitory mechanism, two independent preprint studies reporting concordant findings\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDAN1 dimerizes and forms cytosolic complexes with CDIN1 and multiple copies of ASF1A/B. Cryo-EM structures show CDAN1 engages ASF1 via two B-domains and two helices that mimic histone H3 binding, allowing one CDAN1 to recruit two ASF1 molecules. ASF1A and ASF1B have different requirements for CDAN1 engagement. This sequesters and inhibits ASF1A chaperone function.\",\n      \"method\": \"Single-particle cryo-EM, biochemical reconstitution, in vitro binding assays, comparative ASF1A vs ASF1B analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure plus biochemical reconstitution demonstrating mechanistic inhibition, concordant with independent parallel preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ASF1a (as part of the HIRA complex) fails to localize to PML nuclear bodies in Sp100 knockout keratinocytes even after interferon stimulation. The Sp100A isoform (via its SUMO-interacting motif) is the primary driver of HIRA/UBN1/ASF1a complex localization to PML-NBs.\",\n      \"method\": \"CRISPR-Cas9 Sp100 knockout, immunofluorescence for HIRA/UBN1/ASF1a at PML-NBs, isoform-specific rescue experiments\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with defined localization phenotype, isoform-specific rescue, single preprint study\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ASF1A is a histone H3-H4 chaperone that functions in multiple chromatin contexts: it forms the quaternary HIRA/UBN1/CABIN1/ASF1a (HUCA) complex (where HIRA acts as scaffold) to deposit histone H3.3 in a replication-independent manner and drive SAHF formation and cellular senescence; it acts in DNA double-strand break repair by facilitating ATM-mediated phosphorylation of MDC1 (a role independent of its chaperone activity, promoted by Chk1-mediated phosphorylation at Ser-166) to enable NHEJ; it is regulated by ubiquitin-mediated degradation (via RAD6/MDM2 for degradation and USP52 for stabilization, as well as ATR/CRL1βTRCP-dependent degradation at stalled replication forks); its interaction with downstream chaperones and histones is competitively blocked by CDAN1, which sequesters ASF1A in the cytoplasm via B-domain and histone H3 mimic helix contacts; and it mediates transcriptional regulation by acting as a coactivator for P300-dependent H3K18 lactylation at gene promoters and for the Notch transcriptional complex via H3K56 acetylation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ASF1A is a histone H3-H4 chaperone that operates across replication-independent chromatin assembly, DNA damage signaling, and transcriptional regulation [#5, #15]. In its core assembly role, ASF1A is a member of the HIRA/UBN1/CABIN1/ASF1a (HUCA) quaternary complex in which HIRA serves as scaffold to assemble UBN1, CABIN1, and ASF1a for replication-independent deposition of histone variant H3.3 [#3, #5]; this complex is rate-limiting for senescence-associated heterochromatin foci (SAHF) and senescence-associated cell-cycle exit, and HIRA's transit through PML nuclear bodies is required for SAHF formation [#0, #2]. Structurally, HIRA binds the ASF1a beta-sandwich through an antiparallel B-domain beta-hairpin, and CAF-1 p60 uses B-domain-like motifs to compete for the same surface, making downstream-chaperone engagement mutually exclusive [#1]; in nucleosome assembly ASF1a acts with sNASP, which positions H3 upstream and forms a quaternary complex that folds the H3-H4 dimer [#13]. The chaperone surface is competitively occupied and inhibited by CODANIN-1 (CDAN1), which engages ASF1A via B-domains and histone H3 mimic helices, blocking ASF1/H3-H4 complex formation and sequestering ASF1A in the cytoplasm [#24, #25]. Beyond assembly, ASF1A has a chaperone-independent role in DNA double-strand break repair: it is recruited to breaks, interacts with MDC1, and facilitates ATM-mediated MDC1 phosphorylation to drive RNF8/RNF168-dependent histone ubiquitination, 53BP1 recruitment, and NHEJ, a function specific to ASF1a over ASF1b and promoted by Chk1-mediated phosphorylation at Ser-166 [#15, #20]. ASF1A protein levels are set by ubiquitin-dependent turnover, opposed by USP52-mediated deubiquitination and stabilization, and by ATR/CRL1(\\u03b2TRCP)-dependent degradation at stalled replication forks [#16, #9]. As a transcriptional coactivator, ASF1A promotes H3K56 acetylation at Notch target promoters to enhance RBPJ binding and cooperates with P300 to regulate H3K18 lactylation, while in development its histone-interaction activity resolves bivalent chromatin domains during ES-cell differentiation and assembles H3.3 in the paternal pronucleus [#22, #23, #17, #21].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established that ASF1a physically partners with HIRA and that this complex is rate-limiting for forming senescence-associated heterochromatin and driving senescence cell-cycle exit, defining ASF1a's role in replication-independent chromatin remodeling.\",\n      \"evidence\": \"Co-IP, dominant-negative mutants, and siRNA with colocalization in primary human cells approaching senescence\",\n      \"pmids\": [\"15621527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the full subunit composition of the complex\", \"Mechanism of HIRA entry into PML bodies left open\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved the structural basis of ASF1a partner selection, showing the HIRA B-domain and CAF-1 p60 compete for the same beta-sandwich surface, explaining mutually exclusive downstream-chaperone routing.\",\n      \"evidence\": \"X-ray crystallography of the ASF1a-HIRA heterodimer with biochemical competition and mutagenesis\",\n      \"pmids\": [\"16980972\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the full quaternary complex\", \"Determinants of ASF1a vs ASF1b differential affinity only partly mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified UBN1 as a direct HIRA-binding component of the complex linked to H3K9 methyltransferase activity at repressed genes, extending the senescence assembly machinery beyond ASF1a and HIRA.\",\n      \"evidence\": \"Co-IP, recombinant protein binding, siRNA, and ChIP\",\n      \"pmids\": [\"19029251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How UBN1 directs histone deposition versus methyltransferase recruitment unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Completed the HUCA quaternary complex by adding CABIN1 with HIRA as scaffold and showed it preferentially deposits H3.3 in a replication-independent manner; parallel work placed the HIRA/ASF1a pathway alongside pRB and p53 in SAHF formation and dissected HIRA-specific roles in ALT bodies.\",\n      \"evidence\": \"Reconstitution from recombinant proteins, endogenous Co-IP, epistasis analysis, and comparative HIRA vs ASF1a knockdown in senescent and ALT cells\",\n      \"pmids\": [\"21807893\", \"17242198\", \"21347226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and assembly order within HUCA not fully defined\", \"ASF1a contribution to H3.3 deposition separable from HIRA only partially addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked ASF1a to recovery from the DNA damage checkpoint by showing it restores H3K56 acetylation after UV repair, enabling \\u03b3-H2AX dephosphorylation, while leaving repair itself ASF1a-independent.\",\n      \"evidence\": \"siRNA, ChIP, and \\u03b3-H2AX immunofluorescence in UV-irradiated human cells\",\n      \"pmids\": [\"21727091\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetyltransferase responsible for H3K56Ac restoration not identified here\", \"Mechanistic coupling of H3K56Ac to phosphatase activity unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended ASF1a's chaperone function to host-pathogen chromatin, showing it assembles chromatin on incoming HSV-1 DNA to restrain immediate-early transcription and viral replication.\",\n      \"evidence\": \"siRNA, MNase protection, RT-PCR, and viral growth assays in HeLa cells\",\n      \"pmids\": [\"22951827\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which downstream chaperone partner deposits histones on viral DNA not defined\", \"Direct vs indirect effect on IE transcription not separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Provided the evolutionary and biochemical basis for ASF1a/ASF1b subfunctionalization, mapping N- and C-terminal regions outside the H3-H4 surface as determinants of preferential downstream-chaperone partnering.\",\n      \"evidence\": \"Biochemical binding assays, evolutionary and structural comparison\",\n      \"pmids\": [\"23645555\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequences of MCM9-intronic genomic relocation not tested in cells\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined two layers of ASF1A regulation and function: ATR/CRL1(\\u03b2TRCP)-mediated degradation that drives dechromatinization at stalled forks, and an essential requirement for reprogramming somatic cells to pluripotency.\",\n      \"evidence\": \"Ubiquitination assays with ATR/CRL1\\u03b2TRCP perturbation; oocyte localization plus loss/gain-of-function reprogramming assays\",\n      \"pmids\": [\"24700029\", \"25035411\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether dechromatinization is purely degradation-driven or also active not resolved\", \"Molecular target genes reprogrammed by ASF1A not mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified the degradation machinery for ASF1A, showing the conserved E2 RAD6 cooperates with E3 MDM2 to drive ubiquitin-proteasome turnover.\",\n      \"evidence\": \"Co-IP, in vitro interaction, and ubiquitination assays in Drosophila and human cells\",\n      \"pmids\": [\"26336826\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ubiquitination site(s) on ASF1A not mapped\", \"Signals triggering RAD6/MDM2-dependent turnover unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed ASF1A within reconstituted mismatch repair and the upstream folding pathway, showing CAF-1/ASF1A-H3-H4 deposition is gated by MutS\\u03b1 and that sNASP and ASF1A together fold the H3-H4 dimer; in parallel ASF1a was tied to innate immunity via CBP-dependent H3K56ac at the Ifnb promoter.\",\n      \"evidence\": \"Fully reconstituted in vitro MMR and tetrasome assays; in vitro H3-H4 folding/binding assays; Co-IP, ChIP, and IFN-\\u03b2 assays in macrophages\",\n      \"pmids\": [\"26945061\", \"28123037\", \"27596240\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of MMR-coupled tetrasome deposition not shown\", \"Whether sNASP-ASF1A folding feeds all downstream chaperones untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed a chaperone-independent role for ASF1a in NHEJ, where it recruits to DSBs and promotes ATM-mediated MDC1 phosphorylation to trigger RNF8/RNF168 ubiquitination and 53BP1 recruitment, with specificity over ASF1b.\",\n      \"evidence\": \"Reciprocal Co-IP, siRNA, ChIP, NHEJ assays, foci analysis, and chaperone-dead mutant in human cells\",\n      \"pmids\": [\"28943310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ASF1a is recruited to breaks not fully defined here\", \"Structural basis of ASF1a-MDC1 interaction unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified USP52 as the deubiquitinase opposing ASF1A turnover, stabilizing it to support chromatin assembly and cell-cycle progression, and separately established that ASF1a histone-interaction activity resolves bivalent chromatin during ES-cell differentiation.\",\n      \"evidence\": \"In vitro DUB assay, Co-IP, ubiquitination assays in breast cancer cells; CRISPR deletion, ChIP, and domain-specific mutants in mouse ES cells\",\n      \"pmids\": [\"29599486\", \"29915027\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors recruiting ASF1a to bivalent promoters only partly identified\", \"Balance between USP52 and RAD6/MDM2 in setting ASF1A levels not quantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked ASF1A loss to anti-tumor outcomes, showing its inhibition triggers p53-p21-dependent senescence in WT-p53 cancers and reprograms the tumor microenvironment toward immunogenic macrophages, synergizing with anti-PD-1.\",\n      \"evidence\": \"siRNA with p53-inhibitor epistasis and DNA damage markers; in vivo CRISPR screen, KO, and immune phenotyping in KRAS-mutant lung adenocarcinoma\",\n      \"pmids\": [\"30692519\", \"31744829\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct cause of DNA damage upon ASF1A loss not pinpointed\", \"Mechanism connecting ASF1A loss to GM-CSF upregulation undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined the kinase signaling that activates ASF1A's NHEJ role, showing Chk1 (downstream of ATM) directly phosphorylates Ser-166 to enable the MDC1-ATM interaction in G1, and established ASF1a-specific H3.3 assembly in the paternal pronucleus.\",\n      \"evidence\": \"In vitro kinase assay, phospho-specific antibody, Co-IP, and NHEJ/foci assays in G1-arrested cells; morpholino knockdown with immunofluorescence in mouse embryos\",\n      \"pmids\": [\"33503415\", \"34906203\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ser-166 phosphorylation affects chaperone roles untested\", \"Distinct mechanisms of Asf1a vs Asf1b in embryogenesis only partly resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established ASF1A as a transcriptional coactivator for Notch, depositing H3K56ac at target promoters to enhance RBPJ binding and enforce differentiation arrest in CML blast crisis.\",\n      \"evidence\": \"Co-IP, ChIP for H3K56ac and RBPJ, knockdown, and in vivo CML model\",\n      \"pmids\": [\"36184659\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetyltransferase recruited by ASF1A at Notch promoters not identified\", \"Direct ASF1A-RBPJ contacts not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanded ASF1A coactivator function to histone lactylation and resolved the structural basis of its inhibition, showing ASF1A partners P300 to regulate H3K18la at SNAI1 driving EndMT in atherosclerosis, while CDAN1 sequesters ASF1A in the cytoplasm via B-domains and H3 mimic helices to block H3-H4 binding.\",\n      \"evidence\": \"Co-IP, ChIP for H3K18la, endothelial-specific Asf1a KO in Apoe-null mice; cryo-EM of the CDAN1-ASF1A complex with biochemical reconstitution (preprint)\",\n      \"pmids\": [\"39027248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How P300 and ASF1A jointly select lactylation targets unclear\", \"Cellular triggers controlling CDAN1-mediated cytoplasmic sequestration undefined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified Sp100A as the driver of HUCA complex targeting to PML nuclear bodies, connecting an upstream localization determinant to ASF1a's senescence-associated chromatin functions.\",\n      \"evidence\": \"CRISPR Sp100 knockout with immunofluorescence and isoform-specific rescue in keratinocytes (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single preprint not independently confirmed\", \"Functional consequence of failed PML-NB localization for SAHF not tested here\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ASF1A's multiple roles \\u2014 H3.3/H3-H4 chaperoning, chaperone-independent NHEJ signaling, and transcriptional coactivation via distinct histone modifications \\u2014 are coordinately partitioned within a single cell and switched between contexts remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating chaperone vs non-chaperone functions\", \"Determinants directing ASF1A to assembly vs repair vs transcription unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [5, 13, 17, 1]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [22, 23, 17]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [15, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5, 15]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [24, 25]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [15, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5, 3, 17]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [15, 20, 12]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [22, 23, 17]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 19]}\n    ],\n    \"complexes\": [\"HUCA (HIRA/UBN1/CABIN1/ASF1a)\", \"CDAN1-ASF1A complex\"],\n    \"partners\": [\"HIRA\", \"UBN1\", \"CABIN1\", \"CDAN1\", \"MDC1\", \"USP52\", \"RAD6\", \"EP300\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":6,"faith_pct":100.0}}